Bioventus (BVS) Selling, General & Administrative (2020 - 2026)
Bioventus (BVS) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 4.03 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 2.23 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 1.80 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 561.20 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 358.70 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 1.12 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -179.00 Mn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 369.70 Mn |
| 10 | Bioventus | 967.47 Mn | 938.02 Mn | 105.67 Mn | 82.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 82.74 Mn |
| Mar 28, 2026 | 78.33 Mn |
| Dec 31, 2025 | 82.76 Mn |
| Sep 27, 2025 | 78.66 Mn |
| Jun 28, 2025 | 79.11 Mn |
| Mar 29, 2025 | 73.50 Mn |
| Dec 31, 2024 | 86.87 Mn |
| Sep 28, 2024 | 81.48 Mn |
| Jun 29, 2024 | 96.67 Mn |
| Mar 30, 2024 | 78.78 Mn |
| Dec 31, 2023 | 78.36 Mn |
| Sep 30, 2023 | 69.82 Mn |
| Jul 1, 2023 | 74.84 Mn |
| Apr 1, 2023 | 80.86 Mn |
| Dec 31, 2022 | 77.44 Mn |
| Oct 1, 2022 | 78.96 Mn |
| Jul 2, 2022 | 89.62 Mn |
| Apr 2, 2022 | 86.12 Mn |
| Dec 31, 2021 | 80.88 Mn |
| Oct 2, 2021 | 69.64 Mn |